Clinical Trials Directory

Trials / Completed

CompletedNCT03168555

Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Zealand University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Investigate serial plasma samples of fibroblast growth factor 19 (FGF19) after oral stimulation with chenodeoxycholic acid in the same subjects before and after elective cholecystectomy

Detailed description

Lack of FGF19 and elevated 7-alpha-hydroxy-colestenone (C4) is associated with the bile acid diarrhoea (BAD), a disease with increasing estimated of prevalence. BAD is occasionally triggered by cholecystectomy and FGF19 and C4 is known to be affected by cholecystectomy. The investigators are exploring if FGF19 after oral stimulation can be developed to a universal test for BAD, and need to know how the proposed test is affected by cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGchenodeoxycholic acid1250 mg CDCA is given with a study meal

Timeline

Start date
2017-06-22
Primary completion
2019-05-15
Completion
2019-05-15
First posted
2017-05-30
Last updated
2022-05-19
Results posted
2022-05-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03168555. Inclusion in this directory is not an endorsement.

Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy (NCT03168555) · Clinical Trials Directory